Ardelyx Inc (ARDX)

[jerseyboy]

I agree - I think it will be approved, as it already has approval for treating IBS. My only concern is why tenapanor hasn't seemed to penetrate that market more effectively than it has. They had about $186M in cash and short-term investments as of September 30, and they're burning about $30M of cash per quarter, so they should be fine through early 2022. I also like the company and have a pretty decent stake - I just hope they can market tenapanor better for this indication.